An integrated array of proteins and metabolites, including theophylline, palmitoylethanolamide, hypoxanthine, and CDH5 showed the potential to diagnose advanced COPD patients with a high accuracy. Here, CDH5 is linked to chronic obstructive pulmonary disease.